AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 174,800 shares, an increase of 157.8% from the March 31st total of 67,800 shares. Based on an average trading volume of 2,200 shares, the days-to-cover ratio is currently 79.5 days.

AstraZeneca Stock Up 7.9 %

Shares of AZNCF stock opened at $146.05 on Friday. The firm’s 50 day moving average price is $133.16 and its two-hundred day moving average price is $131.00. AstraZeneca has a 52-week low of $118.16 and a 52-week high of $152.06.

AstraZeneca Increases Dividend

The company also recently announced a dividend, which was paid on Monday, March 25th. Shareholders of record on Friday, February 23rd were issued a $1.97 dividend. The ex-dividend date of this dividend was Wednesday, February 21st. This is a positive change from AstraZeneca’s previous dividend of $0.93. AstraZeneca’s dividend payout ratio (DPR) is 343.14%.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.